Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.470
+1.470 (0.00%)
Feb 28, 2025, 3:00 PM EST
Silence Therapeutics Employees
Silence Therapeutics had 109 employees as of December 31, 2023. The number of employees decreased by 13 or -10.66% compared to the previous year.
Employees
109
Change (1Y)
-13
Growth (1Y)
-10.66%
Revenue / Employee
$496,842
Profits / Employee
-$520,399
Market Cap
212.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
SANUWAVE Health | 31 |
Longduoduo Company | 49 |
Silence Therapeutics News
- 17 days ago - Redmile Group, LLC Acquires Significant Stake in Silence Therapeutics PLC - GuruFocus
- 19 days ago - Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025 - Business Wire
- 20 days ago - Lombard Odier Asset Management's Strategic Acquisition in Silence Therapeutics PLC - GuruFocus
- 21 days ago - Silence Therapeutics hit with new Sell at Goldman Sachs on resource constraints - Seeking Alpha
- 2 months ago - Silence Therapeutics: Simply No Match For Its Orally Dosed Rival (Downgrade) - Seeking Alpha
- 2 months ago - Top 3 Health Care Stocks That May Explode In Q4 - Benzinga
- 2 months ago - Top 3 Health Care Stocks That May Explode In Q4 - Benzinga
- 3 months ago - Silence Therapeutics Presents Promising Phase 1 Data in Polycythemia Vera Patients at the American Society of Hematology (ASH) Annual Meeting - Business Wire